From the Alma Ata declaration in 1978 to the Sustainable Development Goals (SDGs) in 2015, health and healthcare have been a major policy focus worldwide. The concept of healthcare for all has evolved into Universal Health Coverage (UHC), which is part of goal three of the Sustainable Development Goals (SDGs). One key gap towards achieving UHC is access to essential healthcare services. The World Health Organisation (WHO) acknowledges the role of alternative medicines in addressing the gap in access to essential healthcare services. Accordingly, healthcare systems in different countries have evolved to include alternative medicines to achieve the goal of UHC. In India, alternative medicine mainly consists of the stream called AYUSH (Ayurveda, Unani, Yoga, Naturopathy, Siddha, and Homoeopathy) and is a part of the Indian healthcare system. However, gaps remain between the actual and potential performance of healthcare systems. One of the strategies for addressing the gaps has been innovations in healthcare. The Indian government, through its policy initiatives, is encouraging innovative startups, and in the Indian startup ecosystem, the health and wellness segment of startups (which includes alternative medicine) has evolved to address access to healthcare through innovations. Given the importance of access to healthcare services in UHC, it is important to understand this non-clinical dimension for alternative medicine startups. However, there has been no systematic study to explore the services of these innovative alternative medicine startups and their role in access to healthcare. In this context, this study was conducted with the following objectives: 1. To identify the key non-clinical innovations among the alternative medicine startups. 2. To understand the role of these innovations towards addressing access to healthcare. This study used a modified version of Levesque’s framework to understand patient-centred access to healthcare from the supply-side perspective. This modified framework included four dimensions for analysis- Approachability, Acceptability, Availability, and Affordability. The study was qualitative in nature and involved analysis of both primary (interviews of founders of the innovative startups) and secondary data (academic, grey literature, social media, news reports and business reports). Data triangulation from the primary and secondary data sources was conducted to arrive at the findings. Analysis of the 16 innovations identified in this study suggests that alternative medicine startups/companies have used technology as a medium of innovation. The use of technology included the creation of web-based platforms, digital apps, artificial intelligence (AI) and the use of online platforms to sell their products. Digital technology helped to improve the approachability dimension of access to alternative medicine to populations. However, access to digital technology is dependent on infrastructure like power supply, internet connectivity, and penetration of smartphones, which affects the availability dimension of these digital-centric innovations. This makes access to quality-controlled alternative medicine urban-centric. Digital mode of accessing alternative medicine would reduce indirect costs associated with travel time and loss of wages. However, the direct costs associated with accessing these services are dependent on individuals' ability to pay and may negatively affect the affordability dimension. Traditionally, alternative medicines are part of Indian culture and society. Hence, this improves the acceptability dimension of access to healthcare. However, the preference for face-to-face consultations and lower trust in digital interactions in the population negatively affect the acceptability and access to online healthcare consultations. The study recommends that in the current context, there needs to be a mix of digital and non-digital innovations to address the gaps in access to alternative medicine.